key: cord-0865701-k4fzmt5n
authors: Namazi, Nastaran; Diab, Reem; mardani, Ghazal; Jamali, Elena; Kaddah, Ali
title: Figurate purpuric eruption post‐COVID‐19 vaccination
date: 2022-02-15
journal: Dermatol Ther
DOI: 10.1111/dth.15360
sha: 273290e46a16ec4770aa7e8f9679ce587c505e78
doc_id: 865701
cord_uid: k4fzmt5n

nan

Dear Editor, COVID-19 pandemic had spread rapidly all around the world leading to variety of manifestations that ranged from being asymptomatic to death. 1 While COVID-19 vaccination has played a very important role in ending this pandemic, adverse reactions are increasingly reported including cutaneous ones. Injection-site local reactions are among the most common reported cutaneous manifestations, followed by urticaria, pityriasis rosea-like lesions, and pernio/chilblains. 2 Herein we report a post-vaccine urticarial eruption that had unique presentation and could be considered a new urticarial variation following COVID-19 vaccination.

Herein, we report a 58-year-old woman with no significant past medical history presented to our clinic with 1 week history of pruritic lesions on trunk and both lower extremities. The eruption had 

Dermatomyositis-lupus overlap syndrome complicated with cardiomyopathy after SARS-CoV-2 infection: a new potential trigger for musculoskeletal autoimmune disease development

Newonset cutaneous lichen planus triggered by COVID-19 vaccination

Cutaneous adverse effects of the available COVID-19 vaccines

Attention all anti-vaccinators: the cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!

Vaccine-associated hypersensitivity

Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results

COVID-19 vaccineinduced urticarial vasculitis

Cutaneous adverse events related to COVID-19 vaccines: a crosssectional questionnaire based study of 867 patients